Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Influenza: overview on prevention and therapy.

Literature DB >> 31048938

Influenza: overview on prevention and therapy.

Christopher Robson^1,2,3,4,5,6, Sai Rupa Baskar^1,2,3,4,5,6, Robert Booy^1,2,3,4,5,6, Patricia E Ferguson^1,2,3,4,5,6, Nicole Gilroy^1,2,3,4,5,6, Jen Kok^1,2,3,4,5,6, Indy Sandaradura^1,2,3,4,5,6, Dominic Dwyer^1,2,3,4,5,6.

Abstract

Entities: Chemical

Keywords: antivirals; chemoprophylaxis; influenza; vaccines

Year: 2019 PMID： 31048938 PMCID： PMC6478960 DOI： 10.18773/austprescr.2019.013

Source DB: PubMed Journal: Aust Prescr ISSN： 0312-8008

× No keyword cloud information.

35 in total

Review 1. Amantadine and rimantadine for influenza A in adults.

Authors: T Jefferson; V Demicheli; C Di Pietrantonj; D Rivetti
Journal: Cochrane Database Syst Rev Date: 2006-04-19

2. Risk of hospitalization during influenza season among a cohort of patients with congestive heart failure.

Authors: C Sandoval; S D Walter; P Krueger; M Smieja; A Smith; S Yusuf; M B Loeb
Journal: Epidemiol Infect Date: 2006-08-29 Impact factor: 2.451

3. Evidence of person-to-person transmission of oseltamivir-resistant pandemic influenza A(H1N1) 2009 virus in a hematology unit.

Authors: Catherine Moore; Monica Galiano; Angie Lackenby; Tamer Abdelrahman; Rosemary Barnes; Meirion R Evans; Christopher Fegan; Susannah Froude; Mark Hastings; Steven Knapper; Emma Litt; Nicola Price; Roland Salmon; Mark Temple; Eleri Davies
Journal: J Infect Dis Date: 2011-01-01 Impact factor: 5.226

4. Long-acting neuraminidase inhibitor laninamivir octanoate versus oseltamivir for treatment of influenza: A double-blind, randomized, noninferiority clinical trial.

Authors: Akira Watanabe; Shan-Chwen Chang; Min Ja Kim; Daniel Wai-Sing Chu; Yasuo Ohashi
Journal: Clin Infect Dis Date: 2010-10-11 Impact factor: 9.079

5. Oseltamivir ring prophylaxis for containment of 2009 H1N1 influenza outbreaks.

Authors: Vernon J Lee; Jonathan Yap; Alex R Cook; Mark I Chen; Joshua K Tay; Boon Huan Tan; Jin Phang Loh; Seok Wei Chew; Wee Hong Koh; Raymond Lin; Lin Cui; Charlie W H Lee; Wing-Kin Sung; Christopher W Wong; Martin L Hibberd; Wee Lee Kang; Benjamin Seet; Paul A Tambyah
Journal: N Engl J Med Date: 2010-06-10 Impact factor: 91.245

6. Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).

Authors: Anthony E Fiore; Alicia Fry; David Shay; Larisa Gubareva; Joseph S Bresee; Timothy M Uyeki
Journal: MMWR Recomm Rep Date: 2011-01-21

7. Seasonal influenza in adults and children--diagnosis, treatment, chemoprophylaxis, and institutional outbreak management: clinical practice guidelines of the Infectious Diseases Society of America.

Authors: Scott A Harper; John S Bradley; Janet A Englund; Thomas M File; Stefan Gravenstein; Frederick G Hayden; Allison J McGeer; Kathleen M Neuzil; Andrew T Pavia; Michael L Tapper; Timothy M Uyeki; Richard K Zimmerman
Journal: Clin Infect Dis Date: 2009-04-15 Impact factor: 9.079

8. CS-8958, a prodrug of the novel neuraminidase inhibitor R-125489, demonstrates a favorable long-retention profile in the mouse respiratory tract.

Authors: Kumiko Koyama; Makoto Takahashi; Masataka Oitate; Naoko Nakai; Hideo Takakusa; Shin-ichi Miura; Osamu Okazaki
Journal: Antimicrob Agents Chemother Date: 2009-08-17 Impact factor: 5.191

Review 2. Peramivir for influenza.

Authors:
Journal: Aust Prescr Date: 2019-06-17

Review 3. Managing the overlap of asthma and chronic obstructive pulmonary disease.

Authors: Anne Knight
Journal: Aust Prescr Date: 2020-02-03

Review 4. A Tale of Three Recent Pandemics: Influenza, HIV and SARS-CoV-2.

Authors: Mafalda N S Miranda; Marta Pingarilho; Victor Pimentel; Andrea Torneri; Sofia G Seabra; Pieter J K Libin; Ana B Abecasis
Journal: Front Microbiol Date: 2022-06-02 Impact factor: 6.064

4 in total